What's new

Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 26, Status: Authorised

May 7, 2025 - 11:41
 0
Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 26, Status: Authorised
Read More

Tags:

Previous Article

Great Plains Announces Mpala Jena Private Villas, Opening at Zimbabwe’s Mpala Je...

Next Article

Saudi Arabia and US to discuss mining and mineral resources cooperation agreement

Related Posts

Human medicines European public assessment report (EPAR): Winlevi, clascoterone, Status: Opinion

Human medicines European public assessment report (EPAR...

Apr 30, 2025  0

Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 29, 2025  0

Human medicines European public assessment report (EPAR): Evra, norelgestromin,ethinyl estradiol, Date of authorisation: 22/08/2002, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 22, 2025  0